Mayu Yunokawa

35PUBLICATIONS
136CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Dependable systemsMedical ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 26, 2026
Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology.

|Aug 21, 2026
Impact of lymphovascular space invasion on lymph node metastasis in low-grade endometrial cancer with shallow myometrial invasion and negative imaging.

|Apr 09, 2026
Prevalence and clinicopathologic features of mismatch repair-deficient endometrial cancer in Japanese patients younger than 50 years: a single-center prospective observational study.

Hidetaka Nomura, Akiko Abe, Atsushi Fusegi

|Mar 30, 2026
Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer.

Yusuke Toyohara, Mayu Yunokawa, Ryo Nimura

|Jan 28, 2026
Surgical Timing and Survival in Advanced High-Grade Serous Ovarian Cancer in the PARP Inhibitor Era.

Motoko Kanno, Atsushi Fusegi, Naoki Miyazaki

|Sep 19, 2025
Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc.

Munetaka Takekuma, Shin Nishio, Satoshi Yamaguchi

Pageof 6

Frequent Collaborators

14 joint publications

Hiroyuki Kanao

10 joint publications

Atsushi Fusegi

10 joint publications

Hidetaka Nomura

10 joint publications

Motoko Kanno